Andrew Badrot is the founder and CEO of C2 PHARMA, a Luxembourg-based pharmaceutical group that manufactures and distributes active pharmaceutical ingredients and complex chemical compounds obtained from natural and synthetic origins. He has more than 20 years of business experience across various industries. Andrew holds a MS in Financial Engineering from Stanford University, California, USA, and an Engineering degree in Nuclear Physics from Institut Polytechnique in France.
.svg)
